| scholarly article | Q13442814 |
| P2093 | author name string | Oberdörster G | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanotechnology | Q11468 |
| nanomedicine | Q261659 | ||
| P304 | page(s) | 89-105 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Journal of Internal Medicine | Q6295387 |
| P1476 | title | Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology | |
| P478 | volume | 267 |
| Q28389632 | A 3-dimensional in vitro model of epithelioid granulomas induced by high aspect ratio nanomaterials |
| Q92454768 | A Systematic Review of the Genotoxicity and Antigenotoxicity of Biologically Synthesized Metallic Nanomaterials: Are Green Nanoparticles Safe Enough for Clinical Marketing? |
| Q38595356 | A critical review of in vitro dosimetry for engineered nanomaterials |
| Q38394202 | A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). |
| Q33995502 | A general mechanism for intracellular toxicity of metal-containing nanoparticles. |
| Q42849147 | Acute and chronic nephrotoxicity of platinum nanoparticles in mice |
| Q47176098 | Acute intravenous exposure to silver nanoparticles during pregnancy induces particle size and vehicle dependent changes in vascular tissue contractility in Sprague Dawley rats. |
| Q34656597 | Advanced nanobiomaterial strategies for the development of organized tissue engineering constructs. |
| Q57184262 | Air pollution and health: bridging the gap from sources to health outcomes: conference summary |
| Q28388825 | An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials |
| Q53663895 | An occupational exposure assessment for engineered nanoparticles used in semiconductor fabrication. |
| Q92702891 | Aortic Oxidative Stress, Inflammation and DNA Damage Following Pulmonary Exposure to Cerium Oxide Nanoparticles in a Rat Model of Vascular Injury |
| Q33947942 | Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin |
| Q55516366 | Application of Light Scattering Techniques to Nanoparticle Characterization and Development. |
| Q37776159 | Assessing health risks of inhaled nanomaterials: development of pulmonary bioassay hazard studies |
| Q38097389 | Assessing nanoparticle risk poses prodigious challenges. |
| Q38123394 | Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro-in vivo gap. |
| Q39142964 | Assessing orally bioavailable commercial silver nanoparticle product on human cytochrome P450 enzyme activity |
| Q42709049 | Assessment of pulmonary toxicity of MgO nanoparticles in rats |
| Q50624258 | Assessment of the developmental toxicity of nanoparticles in an ex vivo 3D model, the murine limb bud culture system. |
| Q39463167 | Attenuation of endothelial-dependent vasodilator responses, induced by dye-encapsulated silica nanoparticles, in aortic vessels |
| Q61796558 | Autophagic flux blockage in alveolar epithelial cells is essential in silica nanoparticle-induced pulmonary fibrosis |
| Q46408497 | Bioaccumulation and Subchronic Toxicity of 14 nm Gold Nanoparticles in Rats. |
| Q41680918 | Bioactivity of nanosilver in Caenorhabditis elegans: Effects of size, coat, and shape |
| Q42012515 | Biochemical Evaluation of Silver Nanoparticles in Wistar Rats |
| Q43951689 | Biochemical alterations induced by acute oral doses of iron oxide nanoparticles in Wistar rats |
| Q38243437 | Biogenic synthesis of metal nanoparticles from actinomycetes: biomedical applications and cytotoxicity. |
| Q33659702 | Biomedical applications of nanotechnology. |
| Q37843981 | Bionanoelectronics |
| Q38075542 | Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials |
| Q28396571 | Building an ethical foundation for first-in-human nanotrials |
| Q28388084 | Can nanotechnology potentiate photodynamic therapy? |
| Q39256999 | Can the Ames test provide an insight into nano-object mutagenicity? Investigating the interaction between nano-objects and bacteria |
| Q38795672 | Carbon nanotubes: a novel material for multifaceted applications in human healthcare. |
| Q28391763 | Cationic nanoparticles directly bind angiotensin-converting enzyme 2 and induce acute lung injury in mice |
| Q46570686 | Cell cycle dependent cellular uptake of zinc oxide nanoparticles in human epidermal cells |
| Q38250374 | Ceramic nanoparticles: Recompense, cellular uptake and toxicity concerns |
| Q37723684 | Cerium Oxide Nanoparticles in Lung Acutely Induce Oxidative Stress, Inflammation, and DNA Damage in Various Organs of Mice |
| Q28385962 | Coating carbon nanotubes with a polystyrene-based polymer protects against pulmonary toxicity |
| Q46317140 | Combined Action of Human Commensal Bacteria and Amorphous Silica Nanoparticles on the Viability and Immune Responses of Dendritic Cells. |
| Q28395523 | Comparative hazard analysis and toxicological modeling of diverse nanomaterials using the embryonic zebrafish (EZ) metric of toxicity |
| Q38221915 | Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge. |
| Q28394673 | Comprehensive In Vitro Toxicity Testing of a Panel of Representative Oxide Nanomaterials: First Steps towards an Intelligent Testing Strategy |
| Q43465717 | Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra-small superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats |
| Q90151666 | Comprehensive phenotyping and transcriptome profiling to study nanotoxicity in C. elegans |
| Q28478708 | Concentration-dependent, size-independent toxicity of citrate capped AuNPs in Drosophila melanogaster |
| Q28384830 | Concern-driven integrated approaches to nanomaterial testing and assessment--report of the NanoSafety Cluster Working Group 10 |
| Q52685027 | Conventional and novel "omics"-based approaches to the study of carbon nanotubes pulmonary toxicity. |
| Q58781283 | Copper oxide nanoparticles induces oxidative stress and liver toxicity in rats following oral exposure |
| Q39006430 | Cytotoxicity of carbon nanotube variants: a comparative in vitro exposure study with A549 epithelial and J774 macrophage cells |
| Q38180108 | Delivering colloidal nanoparticles to mammalian cells: a nano-bio interface perspective |
| Q27687656 | Development of Taiwan's strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerations |
| Q46149303 | Developmental effects of two different copper oxide nanomaterials in sea urchin (Lytechinus pictus) embryos |
| Q34739019 | Diesel exhaust particle exposure in vitro impacts T lymphocyte phenotype and function |
| Q36650907 | Different biokinetics of nanomedicines linking to their toxicity; an overview |
| Q35827274 | Dispersion Behaviour of Silica Nanoparticles in Biological Media and Its Influence on Cellular Uptake |
| Q37090632 | Distribution and biomarkers of carbon-14-labeled fullerene C60 ([(14) C(U)]C60 ) in female rats and mice for up to 30 days after intravenous exposure. |
| Q26767101 | Drosophotoxicology: An Emerging Research Area for Assessing Nanoparticles Interaction with Living Organisms |
| Q28553476 | Drought Impact Is Alleviated in Sugar Beets (Beta vulgaris L.) by Foliar Application of Fullerenol Nanoparticles |
| Q57765790 | Effect of physico-chemical parameters on the toxicity of inorganic nanoparticles |
| Q28385413 | Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro |
| Q38180306 | Emerging advances in nanomedicine with engineered gold nanostructures |
| Q28395265 | Endocytosis of Multiwalled Carbon Nanotubes in Bronchial Epithelial and Mesothelial Cells. |
| Q28389204 | Engineered nanomaterials in food: implications for food safety and consumer health |
| Q28387517 | Engineered nanomaterials: exposures, hazards, and risk prevention |
| Q89957003 | Enhanced morphological transformation of human lung epithelial cells by continuous exposure to cellulose nanocrystals |
| Q37864336 | Environmental risk analysis for nanomaterials: review and evaluation of frameworks |
| Q39081692 | Estimating the modulatory effects of nanoparticles on neuronal circuits using computational upscaling |
| Q64108523 | Evaluation of the elastic Young’s modulus and cytotoxicity variations in fibroblasts exposed to carbon-based nanomaterials |
| Q28065054 | Evaluation of tumorigenic potential of CeO2 and Fe2O3 engineered nanoparticles by a human cell in vitro screening model |
| Q59113829 | Exposure Assessment Based Recommendations to Improve Nanosafety at Nanoliposome Production Sites |
| Q47169890 | Exposure to Inorganic Nanoparticles: Routes of Entry, Immune Response, Biodistribution and In Vitro/In Vivo Toxicity Evaluation. |
| Q42096284 | Facilitation of trace metal uptake in cells by inulin coating of metallic nanoparticles. |
| Q55113862 | Flexible, Stretchable Sensors for Wearable Health Monitoring: Sensing Mechanisms, Materials, Fabrication Strategies and Features. |
| Q63944613 | From design to the clinic: practical guidelines for translating cardiovascular nanomedicine |
| Q28392143 | Functionalized carbon nanotubes for potential medicinal applications |
| Q26851870 | Functionalized fullerenes in photodynamic therapy |
| Q39540783 | Gd(3+)-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent |
| Q26322763 | Genotoxicity and carcinogenic potential of carbon nanomaterials |
| Q23915904 | Genotoxicity of multi-walled carbon nanotubes at occupationally relevant doses |
| Q37775971 | Glyconanoparticles: multifunctional nanomaterials for biomedical applications. |
| Q36113613 | Gold Nanomaterials in Consumer Cosmetics Nanoproducts: Analyses, Characterization, and Dermal Safety Assessment. |
| Q58309153 | Gold Nanoparticle Determination by Inductively Coupled Plasma-Mass Spectrometry, Anodic Stripping Voltammetry, and Flame Atomic Absorption Spectrophotometry |
| Q38219380 | Graphene nanomaterials as biocompatible and conductive scaffolds for stem cells: impact for tissue engineering and regenerative medicine |
| Q34318312 | Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy |
| Q57508668 | Haloperidol-loaded lipid-core polymeric nanocapsules reduce DNA damage in blood and oxidative stress in liver and kidneys of rats |
| Q48013570 | Health implications of engineered nanomaterials |
| Q42363926 | Health risks associated with the pharmaceuticals in wastewater |
| Q92283862 | Hepatotoxicity and the role of the gut-liver axis in rats after oral administration of titanium dioxide nanoparticles |
| Q29306855 | How toxic are gold nanoparticles? The state-of-the-art |
| Q38818166 | Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer |
| Q34451016 | ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies |
| Q28385227 | Immunotoxicity of silicon dioxide nanoparticles with different sizes and electrostatic charge |
| Q91784828 | Impact of metal oxide nanoparticles on in vitro DNA amplification |
| Q28390126 | Implementation of alternative test strategies for the safety assessment of engineered nanomaterials |
| Q50010257 | In Situ Detection and Single Cell Quantification of Metal Oxide Nanoparticles Using Nuclear Microprobe Analysis. |
| Q60917008 | In Vitro Cytotoxicity Evaluation of the Magnéli Phase Titanium Suboxides (TiO) on A549 Human Lung Cells |
| Q51147702 | In Vitro and In Vivo Short-Term Pulmonary Toxicity of Differently Sized Colloidal Amorphous SiO₂. |
| Q38783468 | In vitro and in vivo evaluation of the toxicities induced by metallic nickel nano and fine particles. |
| Q46947876 | In vitro immunotoxicology of quantum dots and comparison with dissolved cadmium and tellurium |
| Q37423403 | In vivo human time-exposure study of orally dosed commercial silver nanoparticles. |
| Q38813548 | Influence of Nanotoxicity on Human Health and Environment: The Alternative Strategies |
| Q50053549 | Influence of humic acid and dihydroxy benzoic acid on the agglomeration, adsorption, sedimentation and dissolution of copper, manganese, aluminum and silica nanoparticles - A tentative exposure scenario. |
| Q38013743 | Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward |
| Q59336735 | Inhaled nanomaterials and the respiratory microbiome: clinical, immunological and toxicological perspectives |
| Q37602017 | Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation |
| Q95561051 | Integrated approach to the in vivo genotoxic effects of a titanium dioxide nanomaterial using LacZ plasmid-based transgenic mice |
| Q37965056 | Interactions of nanomaterials with the immune system |
| Q28390114 | Intracellular signal modulation by nanomaterials |
| Q38834906 | Investigating the role of shape on the biological impact of gold nanoparticles in vitro |
| Q57197083 | Life cycle assessment at nanoscale: review and recommendations |
| Q57137215 | Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations |
| Q58493179 | Macroscopic to microscopic scales of particle dosimetry: from source to fate in the body |
| Q37055676 | Magnetic particle detection (MPD) for in-vitro dosimetry |
| Q39713763 | Mass or total surface area with aerosol size distribution as exposure metrics for inflammatory, cytotoxic and oxidative lung responses in rats exposed to titanium dioxide nanoparticles |
| Q29248759 | Mechanisms Underlying Cytotoxicity Induced by Engineered Nanomaterials: A Review of In Vitro Studies |
| Q38063536 | Methodological approaches for nanotoxicology using cnidarian models |
| Q39713501 | Metrics, dose, and dose concept: the need for a proper dose concept in the risk assessment of nanoparticles. |
| Q31124745 | Microwave-assisted green synthesis of superparamagnetic nanoparticles using fruit peel extracts: surface engineering, T 2 relaxometry, and photodynamic treatment potential |
| Q35136643 | Modeling Population Exposures to Silver Nanoparticles Present in Consumer Products |
| Q34972497 | Modeling physicochemical interactions affecting in vitro cellular dosimetry of engineered nanomaterials: application to nanosilver |
| Q47221013 | Molecular interactions of different size AuNP-COOH nanoparticles with human fibrinogen. |
| Q28390894 | Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation |
| Q28389786 | Multi-walled carbon nanotube length as a critical determinant of bioreactivity with primary human pulmonary alveolar cells |
| Q28393482 | Multi-walled carbon nanotube-induced inflammatory response and oxidative stress in a dynamic cell growth environment |
| Q39407390 | Multi-walled carbon nanotubes induce cytotoxicity and genotoxicity in human lung epithelial cells. |
| Q26342006 | Multiwalled carbon nanotube-induced pulmonary inflammatory and fibrotic responses and genomic changes following aspiration exposure in mice: a 1-year postexposure study |
| Q50674678 | Nano-QSAR Model for Predicting Cell Viability of Human Embryonic Kidney Cells. |
| Q33919926 | Nano-sized zeolites as modulators of thiacloprid toxicity on Chironomus riparius |
| Q57376199 | Nanobiotechnology: Nanoparticle coronas take shape |
| Q23924128 | Nanomaterials in humans: identification, characteristics, and potential damage |
| Q28073054 | Nanomaterials vs Ambient Ultrafine Particles: an Opportunity to Exchange Toxicology Knowledge |
| Q26775137 | Nanomedicine concepts in the general medical curriculum: initiating a discussion |
| Q57168448 | Nanomedicine: Principles, Properties, and Regulatory Issues |
| Q41225347 | Nanoparticle Formulation of AEA and BAEA Cellulose Carbamates Increases Biocompatibility and Antimicrobial Activity |
| Q58493102 | Nanoparticle Polydispersity Can Strongly Affect In Vitro Dose |
| Q48968218 | Nanoparticle accumulation and transcytosis in brain endothelial cell layers. |
| Q38641001 | Nanoparticle dosage-a nontrivial task of utmost importance for quantitative nanosafety research |
| Q38803240 | Nanoparticle-allergen interactions mediate human allergic responses: protein corona characterization and cellular responses. |
| Q38866857 | Nanoparticles Made From Xyloglucan-Block-Polycaprolactone Copolymers: Safety Assessment for Drug Delivery |
| Q38891729 | Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing |
| Q82791407 | Nanoparticles in the lung |
| Q37880721 | Nanoparticles through the skin: managing conflicting results of inorganic and organic particles in cosmetics and pharmaceutics. |
| Q37760838 | Nanoparticles: molecular targets and cell signalling |
| Q45367836 | Nanosafety: towards safer design of nanomedicines |
| Q23909945 | Nanotechnology: toxicologic pathology |
| Q23909944 | Nanotoxicology - a pathologist's perspective |
| Q50776613 | Nanotoxicology and challenges of translation. |
| Q37893481 | Nanotoxicology and nanoparticle safety in biomedical designs |
| Q37799604 | New developments in aerosol dosimetry. |
| Q23910479 | New perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformatics |
| Q38083258 | New views on cellular uptake and trafficking of manufactured nanoparticles. |
| Q38364473 | No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine |
| Q23919243 | Occupational safety and health, green chemistry, and sustainability: a review of areas of convergence |
| Q36459196 | Odyssey of a cancer nanoparticle: from injection site to site of action |
| Q27691325 | Optical nano antennas: state of the art, scope and challenges as a biosensor along with human exposure to nano-toxicology |
| Q64884294 | Oral administration of titanium dioxide nanoparticle through ovarian tissue alterations impairs mice embryonic development. |
| Q28397619 | Original Research: Evaluation of pulmonary response to inhaled tungsten (IV) oxide nanoparticles in golden Syrian hamsters |
| Q36206957 | Photodynamic therapy with fullerenes in vivo: reality or a dream? |
| Q52720014 | Physical assessment of toxicology at nanoscale: nano dose-metrics and toxicity factor. |
| Q35190894 | Physicochemical characterization of nanoparticles and their behavior in the biological environment |
| Q39384551 | Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses |
| Q38667602 | Plasmonic photothermal therapy of atherosclerosis with nanoparticles: long-term outcomes and safety in NANOM-FIM trial |
| Q28386097 | Potential Occupational Risks Associated with Pulmonary Toxicity of Carbon Nanotubes |
| Q38193126 | Potential environmental implications of nano-enabled medical applications: critical review |
| Q23916998 | Potential pulmonary effects of engineered carbon nanotubes: in vitro genotoxic effects |
| Q29248491 | Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancer |
| Q23923401 | Progression of occupational risk management with advances in nanomaterials |
| Q37651354 | Protein bio-corona: critical issue in immune nanotoxicology |
| Q26322761 | Pulmonary effects of carbon nanomaterials |
| Q40267070 | Pulmonary exposure to metallic nanomaterials during pregnancy irreversibly impairs lung development of the offspring |
| Q38285750 | Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies |
| Q28222668 | QSAR modeling: where have you been? Where are you going to? |
| Q38798528 | Quantifying the magnitude of the oxygen artefact inherent in culturing airway cells under atmospheric oxygen versus physiological levels |
| Q28385022 | Quantitative nanostructure-activity relationship modeling |
| Q42044261 | Quantum dots trigger immunomodulation of the NFκB pathway in human skin cells |
| Q36163772 | Quantum dots: an insight and perspective of their biological interaction and how this relates to their relevance for clinical use. |
| Q39093144 | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Q28396687 | Rat pulmonary responses to inhaled nano-TiO₂: effect of primary particle size and agglomeration state |
| Q28818039 | Rational engineering of physicochemical properties of nanomaterials for biomedical applications with nanotoxicological perspectives |
| Q42080338 | Real-time single airborne nanoparticle detection with nanomechanical resonant filter-fiber |
| Q26822431 | Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field |
| Q51429559 | Redox-active nickel in carbon nanotubes and its direct determination. |
| Q90353559 | Repeated intravenous administration of silica nanoparticles induces pulmonary inflammation and collagen accumulation via JAK2/STAT3 and TGF-β/Smad3 pathways in vivo |
| Q56976666 | Respiratory epithelial cytotoxicity and membrane damage (holes) caused by amine-modified nanoparticles |
| Q42677240 | Response to the Reply on behalf of the 'Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area' (MAK Commission) by Andrea Hartwig Karlsruhe Institute of Technology (KIT). |
| Q36740542 | Responsible conduct in nanomedicine research: environmental concerns beyond the common rule |
| Q37791170 | Review of carbon nanotubes toxicity and exposure--appraisal of human health risk assessment based on open literature |
| Q37783718 | Review of fullerene toxicity and exposure--appraisal of a human health risk assessment, based on open literature |
| Q48353622 | Reviewing the regulatory barriers for nanomedicine: global questions and challenges. |
| Q52584444 | Risk Assessment and Risk Minimization in Nanomedicine: A Need for Predictive, Alternative, and 3Rs Strategies. |
| Q37089117 | Risk assessment of amorphous silicon dioxide nanoparticles in a glass cleaner formulation |
| Q34468073 | Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review |
| Q39447640 | Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population |
| Q28260935 | STED microscopy and its applications: new insights into cellular processes on the nanoscale |
| Q92892016 | Safety Assessment of Nanomaterials to Eyes: An Important but Neglected Issue |
| Q28383164 | Safety evaluation of engineered nanomaterials for health risk assessment: an experimental tiered testing approach using pristine and functionalized carbon nanotubes |
| Q28083076 | Safety of Nanoparticles in Medicine |
| Q28390232 | Scavenger receptor mediated endocytosis of silver nanoparticles into J774A.1 macrophages is heterogeneous |
| Q34000813 | Silver nanoparticles disrupt GDNF/Fyn kinase signaling in spermatogonial stem cells. |
| Q39140394 | Singlet oxygen plays a key role in the toxicity and DNA damage caused by nanometric TiO2 in human keratinocytes. |
| Q57925206 | Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review. |
| Q34405303 | Sneezing and allergic dermatitis were increased in engineered nanomaterial handling workers |
| Q30393869 | Sub-acute intravenous administration of silver nanoparticles in male mice alters Leydig cell function and testosterone levels. |
| Q46523409 | Synthesis and in vitro safety assessment of magnetic bacterial cellulose with porcine aortic smooth muscle cells |
| Q88956380 | Synthesis, Purification, Characterization, and Imaging of Cy3-Functionalized Fluorescent Silver Nanoparticles in 2D and 3D Tumor Models |
| Q90862847 | Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles |
| Q58909310 | The Effect of Nanoclay on Dust Generation during Drilling of PA6 Nanocomposites |
| Q47360206 | The Toxicity of Nanoparticles Depends on Multiple Molecular and Physicochemical Mechanisms |
| Q33565106 | The acute pulmonary and thrombotic effects of cerium oxide nanoparticles after intratracheal instillation in mice |
| Q28393485 | The application of carbon nanotubes in target drug delivery systems for cancer therapies |
| Q57425326 | The bench scientist’s perspective on the unique considerations in nanoparticle regulation |
| Q27013605 | The biomechanisms of metal and metal-oxide nanoparticles' interactions with cells |
| Q36530323 | The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice |
| Q84306714 | The dose makes the poison |
| Q37139223 | The effects of nanomaterials as endocrine disruptors |
| Q38838210 | The effects of nanoparticles on the renal system |
| Q28390743 | The new toxicology of sophisticated materials: nanotoxicology and beyond |
| Q38857110 | The promotion of salinomycin delivery to hepatocellular carcinoma cells through EGFR and CD133 aptamers conjugation by PLGA nanoparticles |
| Q35270450 | The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles |
| Q39067376 | The role of iron impurities in the toxic effects exerted by short multiwalled carbon nanotubes (MWCNT) in murine alveolar macrophages. |
| Q38968338 | The role of p53 in lung macrophages following exposure to a panel of manufactured nanomaterials. |
| Q33774310 | The shape and size of hydroxyapatite particles dictate inflammatory responses following implantation |
| Q39431201 | Three-dimensional hydrogel constructs for exposing cells to nanoparticles |
| Q57425302 | TiO2 nanoparticle-induced ROS correlates with modulated immune cell function |
| Q39226247 | Titanium dioxide nanoparticles induce matrix metalloprotease 1 in human pulmonary fibroblasts partly via an interleukin-1β-dependent mechanism. |
| Q33639595 | Toward a molecular understanding of nanoparticle-protein interactions |
| Q46966188 | Toxicity evaluation of engineered nanoparticles for medical applications using pulmonary epithelial cells |
| Q57765661 | Toxicity evaluation of inorganic nanoparticles: considerations and challenges |
| Q89537004 | Toxicity of Carbon Nanotubes as Anti-Tumor Drug Carriers |
| Q53082340 | Toxicity of single-wall carbon nanotubes functionalized with polyethylene glycol in zebrafish (Danio rerio) embryos. |
| Q39692911 | Toxicity of zinc oxide nanoparticles through oral route |
| Q58910215 | Toxicological Effects of Titanium Dioxide Nanoparticles: A Review ofIn VivoStudies |
| Q28395046 | Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems |
| Q23914977 | Toxicology of nanomaterials used in nanomedicine |
| Q39345498 | Toxicology of silica nanoparticles: an update |
| Q38472660 | Tracing engineered nanomaterials in biological tissues using coherent anti-Stokes Raman scattering (CARS) microscopy - A critical review |
| Q28387090 | Transcriptional activation of follistatin by Nrf2 protects pulmonary epithelial cells against silica nanoparticle-induced oxidative stress |
| Q34065785 | Translational considerations for cancer nanomedicine |
| Q28394812 | Translational toxicology in setting occupational exposure limits for dusts and hazard classification - a critical evaluation of a recent approach to translate dust overload findings from rats to humans |
| Q61443753 | Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection |
| Q96576642 | Ultrafine silicon dioxide nanoparticles cause lung epithelial cells apoptosis via oxidative stress-activated PI3K/Akt-mediated mitochondria- and endoplasmic reticulum stress-dependent signaling pathways |
| Q36855789 | Ultrasmall superparamagnetic iron oxide nanoparticles acutely promote thrombosis and cardiac oxidative stress and DNA damage in mice |
| Q28392557 | Ultrastructural interactions and genotoxicity assay of cerium dioxide nanoparticles on mouse oocytes |
| Q57640600 | Understanding the interaction of multi-walled carbon nanotubes with mutagenic organic pollutants using computational modeling and biological experiments |
| Q91118452 | Universal nanohydrophobicity predictions using virtual nanoparticle library |
| Q44949624 | Urokinase-coated chitosan nanoparticles for thrombolytic therapy: preparation and pharmacodynamics in vivo |
| Q45018868 | ZnS nanoarchitectures induced dysfunction of vascular endothelial cells in vitro and in vivo |
| Q27022043 | siRNA delivery to the lung: what's new? |
Search more.